135 (Nimodipine 30 mg)
Pill with imprint 135 is Yellow, Capsule-shape and has been identified as Nimodipine 30 mg. It is supplied by Caraco Pharmaceutical Laboratories.
Nimodipine is used in the treatment of subarachnoid hemorrhage; migraine prevention; ischemic stroke and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nimodipine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 135
Nimodipine
- Imprint:
- 135
- Strength:
- 30 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Caraco Pharmaceutical Laboratories
- Inactive Ingredients:
- glycerin
peppermint oil
water
polyethylene glycol
gelatin
D&C Yellow No. 10
titanium dioxide
ammonia
ferrosoferric oxide
butyl alcohol
isopropyl alcohol
shellac
alcohol
propylene glycol
medium-chain triglycerides
Note: Inactive ingredients may vary.
More about nimodipine
- Nimodipine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: calcium channel blocking agents
Consumer resources
Other brands: Nimotop, Nymalize
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
